Carmell Therapeutics Corporation (CTCX) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Carmell Therapeutics Corporation (CTCX) has a cash flow conversion efficiency ratio of 0.198x as of March 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-752.95K) by net assets ($-3.81 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see market cap of Carmell Therapeutics Corporation for the company's overall valuation and market capitalisation.
Carmell Therapeutics Corporation - Cash Flow Conversion Efficiency Trend (2021–2024)
This chart illustrates how Carmell Therapeutics Corporation's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Carmell Therapeutics Corporation Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Carmell Therapeutics Corporation ranked by their cash flow conversion efficiency. Explore Carmell Therapeutics Corporation cash flow quality index to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Huachen AI Parking Management Technology Holding Co Ltd
NASDAQ:HCAI
|
-1.045x |
|
CARLSON INV. ZY 13
F:2HB
|
-0.001x |
|
Nandani Creation Limited
NSE:JAIPURKURT
|
-0.166x |
|
Instituto Rosenbusch S.A.
BA:ROSE
|
-1.542x |
|
DSS Inc
NYSE MKT:DSS
|
-0.290x |
|
WORK Medical Technology Group LTD Ordinary Shares
NASDAQ:WOK
|
0.427x |
|
CC Japan Income and Growth Trust PLC
LSE:CCJI
|
-0.007x |
|
MPC Energy Solutions NV
OL:MPCES
|
0.002x |
Annual Cash Flow Conversion Efficiency for Carmell Therapeutics Corporation (2021–2024)
The table below shows the annual cash flow conversion efficiency of Carmell Therapeutics Corporation from 2021 to 2024. View CTCX live share price for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $-4.71 Million | $-4.39 Million | 0.931x | +376.10% |
| 2023-12-31 | $24.75 Million | $-8.35 Million | -0.337x | -471.78% |
| 2022-12-31 | $-37.79 Million | $-3.43 Million | 0.091x | +128.03% |
| 2021-12-31 | $-29.58 Million | $-1.18 Million | 0.040x | -- |
About Carmell Therapeutics Corporation
Carmell Corporation operates as a bio-aesthetics company. The company utilizes Carmell Secretome to support skin and hair health. Its Carmell Secretome consists of growth factors and proteins extracted from allogeneic human platelets sourced from tissue banks. The company also developed a microemulsion formulation that enables delivery of lipophilic and hydrophilic ingredients without relying on … Read more